Joe Anderson CEO of ARIX Bioscience on exciting early stage life science businesses to market and an update from LVCG

On Today's Vox Markets Podcast: Joe Anderson CEO of ARIX Bioscience on exciting early stage life science businesses to market and an update from LVCG

Arix Bioscience is a global healthcare and life science company that drives value in private and public companies through operational and strategic direction as well as patient capital Led by renowned figures in the healthcare and life science sectors, Arix Bioscience is headquartered in London and has an office in New York. Our extensive experience in academic science, clinical and commercial strategy, company operations, mergers and acquisitions, venture capital and corporate finance puts us in an especially strong position to build and support a wide range of businesses and technologies. Arix Bioscience has privileged agreements with leading universities in the UK, Europe and Australia, providing direct access to innovative new technologies. We also have access to a broad range of research projects from US academic institutions.

Live Company Group (AIM: LVCG) is a leading Live Events and Entertainment company. LVCG was founded in 2017 by its Chairman, David Ciclitira and is admitted to trading on the AIM market of the London Stock Exchange. The Company’s country of incorporation and main country of operation is the United Kingdom.